Page last updated: 2024-08-24

cephalosporin c and Bacterial Skin Diseases

cephalosporin c has been researched along with Bacterial Skin Diseases in 112 studies

Research

Studies (112)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's15 (13.39)18.2507
2000's25 (22.32)29.6817
2010's67 (59.82)24.3611
2020's5 (4.46)2.80

Authors

AuthorsStudies
Claeys, KC; Davis, SL; Delaportes, DJ; Estrada, SJ; Huang, V; Jorgensen, SCJ; Kaye, KS; Klinker, KP; Lagnf, AM; Rybak, MJ; Trinh, TD; Zasowski, EJ1
Flamm, RK; Pfaller, MA; Shortridge, D; Streit, JM1
Buonomo, AR; Congera, P; Foggia, M; Gentile, I; Maraolo, AE; Parente, S; Scotto, R; Zappulo, E1
Hsueh, PR; Jean, SS; Ko, WC1
Engelhardt, M; Gonzalez-Rojas, Y; Gumenchuk, I; Hamed, KA; Ionescu, D; Jones, ME; Keech, R; Kim, C; Ninov, B; Overcash, JS; Saulay, M; Simeonov, S; Smart, JI; Waters, M1
Engelhardt, M; Hamed, K; Overcash, JS; Saulay, M; Scheeren, TW; Welte, T1
Castanheira, M; Flamm, RK; Jones, RN; Mendes, RE; Pfaller, MA; Sader, HS1
Bassetti, M; Castaldo, N; Givone, F; Peghin, M; Righi, E; Sartor, A1
Cho, YL; Kim, HS; Kwak, JH; Oh, K; Oh, SH; Park, HS; Yun, JY1
Arcenillas, P; Boix-Palop, L; Calbo, E; Cuchi, E; Dietl, B; Gómez, L; González de Molina, FJ; Nicolás, J; Sánchez, I1
Artioli, S; Bassetti, M; Capone, A; Carannante, N; Castaldo, N; Cattelan, A; Cipriani, L; Coletto, D; Digaetano, M; Grossi, P; Losito, AR; Mastroianni, CM; Menichetti, F; Mussini, C; Nicolè, S; Peghin, M; Righi, E; Russo, A; Tascini, C; Tumbarello, M; Vena, A1
Corey, GR; Das, S; Dryden, M; Friedland, HD; Gonzalez, J; Iaconis, J; Jandourek, A; Wilcox, MH; Wilson, DJ1
Barberán, J1
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS3
Flamm, RK; Jones, RN; Sader, HS1
Beresford, E; Friedland, HD; Huang, X; Lodise, T1
Ambrose, PG; Bhavnani, SM; Forrest, A; Khariton, T; Reynolds, DK; Riccobene, T; Rubino, CM; Van Wart, SA1
David Friedland, H; Davis, A; Jandourek, A; Santos, PD; Smith, A1
Flamm, RK; Jones, RN; Pfaller, MA; Sader, HS1
Beresford, E; Biek, D; Friedland, HD; Jandourek, A; Mawal, Y; Riccobene, T1
Barber, KE; Barr, VO; Casapao, AM; Davis, SL; Goff, DA; Kaye, KS; Klinker, KP; Molloy, LM; Mynatt, RP; Pogue, JM; Rybak, MJ1
Hata, Y; Iketani, Y; Oguri, T; Yamamoto, N1
Barberán, J; Cisneros, JM1
Holmes, NE; Howden, BP1
Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS1
Cole, P; Evans, J; Friedland, HD; Udeani, G1
Cole, P; Evans, JD; Friedland, HD; Udeani, G1
Eckmann, C2
Cole, P; Friedland, HD; Maggiore, C; Pasquale, T1
Canut, A; Isla, A; Rodríguez-Gascón, A1
Castanheira, M; Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS1
Cole, P; Friedland, HD; Guervil, DJ; Hassoun, A; Huang, XY; Kaye, KS1
Cates, JE; Li, G; Mitrani-Gold, FS; Mundy, LM1
Ahmed, S; Ali, SA; Arsalan, A; Naqvi, SB; Shakeel, O1
James, D; Kearns, A; Livermore, DM; Mushtaq, S; Warner, M; Woodford, N1
Biedenbach, DJ; Bouchillon, SK; Iaconis, JP; Karlowsky, JA; Reiszner, E; Sahm, DF1
Antadze, T; Bradley, JS; Giorgobiani, M; Jandourek, A; Korczowski, B; O'Neal, T; Smith, A; Stryjewski, ME1
Biedenbach, DJ; Bouchillon, SK; Hackel, M; Iaconis, JP; Karlowsky, JA; Sahm, DF1
Bradley, JS; Carrothers, TJ; Das, S; Jandourek, A; Khariton, T; Knebel, W; Li, J; Riccobene, TA1
Dryden, M; Gonzalez, J; Iaconis, JP; Wilson, D; Zhang, Y1
Crespo Casal, M; Martinez-Lamas, L; Nodar, A; Perez-Landeiro, A; Perez-Rodríguez, MT; Sousa Dominguez, A1
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R1
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W1
Cohen, R; Raymond, J1
Cohen, R; Gillet, Y; Moulin, F; Quinet, B; Raymond, J1
Corey, GR; Kanafani, ZA1
Biedenbach, DJ; Jones, RN1
Cabeza, J; Carrasco, C; Gutierrez, J; Sorlozano, A; Villegas, E1
Deresinski, SC; Schirmer, PL1
Corey, GR; Nannini, EC; Stryjewski, ME1
Cooper, C; Kim, PW; Kornegay, C; Nambiar, S; Rochester, G; Valappil, T; Wang, Y; Wu, YT1
Baculik, T; Corey, GR; Critchley, I; Das, AF; Friedland, HD; Talbot, GH; Thye, D; Wilcox, M; Witherell, GW1
Jones, RN; Mendes, RE; Sader, HS1
Moellering, RC1
Drusano, GL2
Baculik, T; Corey, GR; Friedland, D; Talbot, GH; Thye, D; Wilcox, MH2
Corrado, ML1
Biek, D; Critchley, IA; Riccobene, TA; Thye, DA1
Kanafani, ZA1
Kelly, N; Papp, R; Popovic, A; Tschirret-Guth, R1
Jain, A; Kaushik, D; Rathi, S1
Kalil, AC1
Laudano, JB1
Belavic, JM1
Carver, PL; DePestel, DD; Jorgenson, MR1
Wilcox, MH1
Biek, D; Eckburg, PB; Friedland, HD; Laudano, JB; Llorens, L; O'Neal, T; Rank, DR; Smith, A; Thye, D; Witherell, GW1
Nikitin, AV1
Casapao, AM; Levine, DP; Rybak, MJ; Steed, ME1
Lodise, TP; Low, DE1
Leakey, A; Morrissey, I; Northwood, JB1
Barriere, SL; Churukian, A; Corey, GR; Kingsley, J; Li, YP; Potgieter, PD; Stryjewski, ME1
Coutinho, AS; de Morais, OO; de Oliveira Carneiro da Motta, J; Gomes, CM1
Balbisi, EA1
Devcich, KJ; París, MM1
Fritsche, TR; Jones, RN; Sader, HS; Streit, JM1
Jones, RN; Sader, HS1
Del Rosso, J1
Hedrick, J1
Akinlade, BK; Busman, TA; Cifaldi, M; Elston, D; Giordano, PA; Nilius, AM; Notario, GF; Weber, K1
Noel, GJ1
Amsler, K; Heep, M; Noel, GJ; Pypstra, R; Solomkin, JS; Strauss, RS1
Bagchi, P; Bush, K; Ianus, J; Noel, GJ; Strauss, RS1
Fritsche, TR; Gorodecky, E; Jones, RN; Lodise, TP; Patel, N; Renaud-Mutart, A1
Deresinski, SC1
Nolen, T1
Azuma, E; Ihara, T; Ito, M; Kamiya, H; Kitamura, K; Sakurai, M1
Boiron, P; Freland, C; Fur, JL; Lelong, P; Nemirovsky-Trebucq, B1
Das-Young, LR; Frank, E; Ramirez-Ronda, C; Schwartz, R1
Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C1
Chen, DK; Chen, YF; Gu, JM; Hou, J; Hu, WZ; Jia, YX; Li, JT; Li, LJ; Liu, DM; Lu, Y; Miao, JZ; Sun, L; Wang, HL; Wang, Z; Wu, J; Zhang, XZ; Zhang, YL1
Alekseev, AA; Blatun, LA; Iakovlev, VP; Izotova, GN; Krutikov, MG; Puchkova, LS; Svetukhin, AM1
Amodio-Groton, M; Epstein, ME; Sadick, NS1
Fujiyama, S; Tanaka, M1
Darmstadt, GL1
Bhutta, ZA; Ladhani, S1
Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O1
Asumang, A; Dryden, M; Goldsmith, AL1
Azimi, PH; Barson, WJ; Janner, D; Swanson, R1
Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M1
Kaya, O; Kirkan, S; Unal, B1
Church, D; Fidelholtz, J; Haverstock, D; Heyd, A; Miskin, B; Parish, LC; Routh, HB; Werschler, P1
Aragane, Y; Asai, M; Kawada, A; Maeda, A; Shiraishi, H; Tezuka, T1
SoRelle, R1
Thompson, CA1
Bushnell, WD; Capin, LR; Cupo, MA; Parish, LC; Rist, T; Sulica, V1

Reviews

29 review(s) available for cephalosporin c and Bacterial Skin Diseases

ArticleYear
Possible clinical indications of ceftobiprole.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32 Suppl 3

    Topics: Anti-Bacterial Agents; Bacterial Infections; Catheter-Related Infections; Cephalosporins; Cross Infection; Diabetic Foot; Fever of Unknown Origin; Humans; Inpatients; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections

2019
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.
    Expert review of clinical pharmacology, 2014, Volume: 7, Issue:2

    Topics: Acute Disease; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Approval; Drug Design; Drug Interactions; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Staphylococcal Infections; United States; United States Food and Drug Administration

2014
What's new in the treatment of serious MRSA infection?
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2014
Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Humans; Linezolid; Randomized Controlled Trials as Topic; Skin; Skin Diseases, Bacterial

2015
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
    BMC infectious diseases, 2017, 01-07, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2017
Ceftaroline: a cephalosporin with expanded Gram-positive activity.
    Future microbiology, 2009, Volume: 4, Issue:1

    Topics: Adult; Animals; Ceftaroline; Cephalosporins; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Mice; Skin Diseases, Bacterial; Treatment Outcome

2009
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Bacterial; Europe; Humans; Latin America; Microbial Sensitivity Tests; North America; Respiratory Tract Infections; Skin Diseases, Bacterial

2009
Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.
    Expert review of anti-infective therapy, 2009, Volume: 7, Issue:7

    Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Skin Diseases, Bacterial; Treatment Outcome

2009
Meta-analysis of a possible signal of increased mortality associated with cefepime use.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Aug-15, Volume: 51, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Fever of Unknown Origin; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neutropenia; Pneumonia, Bacterial; Skin Diseases, Bacterial; Survival Analysis; Urinary Tract Infections; Young Adult

2010
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4

    Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome

2010
Ceftaroline: a comprehensive update.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Drug Approval; Humans; Pneumonia, Bacterial; Prodrugs; Skin Diseases, Bacterial; Soft Tissue Infections; United States

2011
Ceftaroline fosamil: a new broad-spectrum cephalosporin.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66 Suppl 3

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pneumonia, Bacterial; Prodrugs; Skin Diseases, Bacterial; Soft Tissue Infections; United States

2011
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:11

    Topics: Animals; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Evaluation, Preclinical; Humans; Methicillin-Resistant Staphylococcus aureus; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Infections

2011
MRSA new treatments on the horizon: current status.
    Injury, 2011, Volume: 42 Suppl 5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Glycopeptides; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Teicoplanin

2011
[Ceftaroline fosamil, a broad spectrum cephalosporin antibiotic for the treatment of community-acquired pneumonia and complicated skin and skin structure infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:7-8

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Pneumonia, Bacterial; Skin Diseases, Bacterial

2011
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.
    Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:8

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Pneumonia, Bacterial; Skin Diseases, Bacterial

2012
Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
    Drugs, 2012, Jul-30, Volume: 72, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Double-Blind Method; Humans; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial

2012
Cefditoren, a new aminothiazolyl cephalosporin.
    Pharmacotherapy, 2002, Volume: 22, Issue:10

    Topics: Acute Disease; Bacterial Infections; Bronchitis, Chronic; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Interactions; Humans; Maxillary Sinusitis; Pharyngitis; Pneumonia, Bacterial; Skin Diseases, Bacterial

2002
Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections.
    Cutis, 2004, Volume: 73, Issue:5 Suppl

    Topics: Adult; Anti-Infective Agents; Cefdinir; Cephalosporins; Child; Humans; Skin Diseases, Bacterial; Soft Tissue Infections

2004
Therapeutic experience with cefdinir in the treatment of uSSSIs.
    International journal of clinical practice, 2006, Volume: 60, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Female; Humans; Male; Skin Diseases, Bacterial

2006
Cephalosporins for uncomplicated skin and skin structure infections in emerging community-acquired MRSA.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:15

    Topics: Adult; Cephalosporins; Child; Community-Acquired Infections; Humans; Methicillin Resistance; Skin Diseases, Bacterial; Staphylococcal Skin Infections

2006
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2007, Volume: 13 Suppl 2

    Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcal Skin Infections

2007
Pharmacokinetic and pharmacodynamic profile of ceftobiprole.
    Diagnostic microbiology and infectious disease, 2008, Volume: 61, Issue:1

    Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Monte Carlo Method; Pneumonia; Skin Diseases, Bacterial

2008
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.
    Diagnostic microbiology and infectious disease, 2008, Volume: 61, Issue:1

    Topics: Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Treatment Outcome

2008
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:10

    Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections

1994
Primary cutaneous nocardiosis caused by Nocardia otitidiscaviarum: two cases and a review of the literature.
    The Journal of tropical medicine and hygiene, 1995, Volume: 98, Issue:6

    Topics: Abscess; Adult; Anti-Bacterial Agents; Cephalexin; Cephalosporins; Female; France; Gentamicins; Humans; Male; Middle Aged; Minocycline; Mycetoma; Nocardia; Nocardia Infections; Skin Diseases, Bacterial; Travel; Vietnam; Zimbabwe

1995
Antimicrobial agents for the dermatologist. I. Beta-lactam antibiotics and related compounds.
    Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:2 Pt 1

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Combinations; Humans; Monobactams; Skin Diseases, Bacterial

1997
[Vibrio vulnificus infections].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, May-10, Volume: 87, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Risk Factors; Seasons; Sepsis; Skin Diseases, Bacterial; Tetracyclines; Vibrio; Vibrio Infections

1998
Antibiotics in the management of pediatric skin disease.
    Dermatologic clinics, 1998, Volume: 16, Issue:3

    Topics: 4-Quinolones; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Child; Drug Resistance, Microbial; Humans; Infant; Macrolides; Penicillins; Skin Diseases, Bacterial; Staphylococcus aureus; Tetracyclines

1998

Trials

23 trial(s) available for cephalosporin c and Bacterial Skin Diseases

ArticleYear
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-05, Volume: 73, Issue:7

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin

2021
Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia.
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Models, Biological; Pneumonia, Bacterial; Skin Diseases, Bacterial; Young Adult

2013
A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:8

    Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus pyogenes; Treatment Outcome

2016
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:12

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin; Young Adult

2016
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus

2008
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Sep-15, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult

2010
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4

    Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult

2010
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult

2010
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4

    Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin

2010
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Biomarkers; Ceftaroline; Cephalosporins; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin

2012
TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Glycopeptides; Humans; Injections, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin; Skin Diseases, Bacterial; Staphylococcal Infections; Vancomycin

2012
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Current medical research and opinion, 2006, Volume: 22, Issue:12

    Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Cefdinir; Cellulitis; Cephalexin; Cephalosporins; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Skin Diseases, Bacterial; Staphylococcus aureus; Staphylococcus epidermidis; Wound Infection

2006
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin

2008
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Mar-01, Volume: 46, Issue:5

    Topics: Aged; Ceftazidime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin

2008
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.
    Diagnostic microbiology and infectious disease, 2008, Volume: 61, Issue:1

    Topics: Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Treatment Outcome

2008
Current and future management of serious skin and skin-structure infections.
    The American journal of medicine, 1996, Jun-24, Volume: 100, Issue:6A

    Topics: Bacteria; Cefepime; Ceftazidime; Cephalosporins; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Skin Diseases; Skin Diseases, Bacterial

1996
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections

1997
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Skin Diseases, Bacterial; Sulbactam; Urinary Tract Infections

1997
[Use of cefpirome in the treatment of patients with skin and soft tissue infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1996, Volume: 41, Issue:12

    Topics: Adolescent; Adult; Burns; Cefpirome; Cephalosporins; Humans; Microbial Sensitivity Tests; Middle Aged; Necrosis; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Wound Infection

1996
Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
    The Pediatric infectious disease journal, 1999, Volume: 18, Issue:7

    Topics: Ampicillin; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Prospective Studies; Skin Diseases, Bacterial; Sulbactam; Treatment Outcome

1999
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin

1999
Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.
    International journal of clinical practice, 2000, Volume: 54, Issue:8

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Infective Agents; Cephalexin; Cephalosporins; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Streptococcal Infections; Therapeutic Equivalency; Treatment Outcome

2000
A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema.
    Clinical and experimental dermatology, 2002, Volume: 27, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Anti-Bacterial Agents; Cephalexin; Cephalosporins; Diarrhea; Double-Blind Method; Drug Administration Schedule; Eczema; Female; Humans; Male; Middle Aged; Mupirocin; Ointments; Opportunistic Infections; Patient Satisfaction; Skin Diseases, Bacterial

2002

Other Studies

61 other study(ies) available for cephalosporin c and Bacterial Skin Diseases

ArticleYear
Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:11

    Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Humans; Male; Middle Aged; Retrospective Studies; Skin; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin

2019
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.
    Journal of global antimicrobial resistance, 2020, Volume: 21

    Topics: Asia; Cephalosporins; Europe; Female; Global Health; Humans; Latin America; Male; Microbial Sensitivity Tests; North America; Pacific Islands; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Public Health Surveillance; Sepsis; Skin Diseases, Bacterial; Tazobactam

2020
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience.
    Infection, 2020, Volume: 48, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome

2020
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (AT
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftaroline; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Taiwan

2020
Efficacy and safety of ceftobiprole in patients aged 65 years or older: a 
    Future microbiology, 2021, Volume: 16

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Pneumonia; Skin Diseases, Bacterial; Treatment Outcome

2021
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.
    The Pediatric infectious disease journal, 2017, Volume: 36, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Haemophilus influenzae; Hospitals; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Retrospective Studies; Skin Diseases, Bacterial; Staphylococcal Infections; Streptococcus pneumoniae; United States

2017
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.
    Journal of global antimicrobial resistance, 2017, Volume: 9

    Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome

2017
Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Female; Humans; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Siderophores; Skin Diseases, Bacterial; Treatment Outcome; Urinary Tract Infections

2017
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.
    International journal of antimicrobial agents, 2018, Volume: 51, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Osteomyelitis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome

2018
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
    International journal of antimicrobial agents, 2019, Volume: 53, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bone Diseases, Infectious; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Skin Diseases, Bacterial; Tazobactam; Treatment Outcome; Urinary Tract Infections

2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.
    International journal of antimicrobial agents, 2019, Volume: 53, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Diseases, Bacterial; Systemic Inflammatory Response Syndrome; Treatment Outcome

2019
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Escherichia coli; Europe; Gram-Positive Cocci; Humans; Klebsiella; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections

2013
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:1

    Topics: Anti-Bacterial Agents; Asia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; South Africa; Staphylococcus aureus; Streptococcus pneumoniae

2013
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Jun-15, Volume: 70, Issue:12

    Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Costs and Cost Analysis; Drug Therapy, Combination; Economics, Hospital; Formularies, Hospital as Topic; Humans; Length of Stay; Models, Economic; Skin Diseases, Bacterial; Vancomycin

2013
Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.
    Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Skin; Skin Diseases, Bacterial; Skin Diseases, Infectious; Staphylococcal Infections; Young Adult

2013
Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).
    Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:4

    Topics: Academic Medical Centers; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; United States

2014
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012).
    Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:4

    Topics: Academic Medical Centers; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria; Ceftaroline; Cephalosporins; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; United States

2014
Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Skin Diseases, Bacterial

2014
[Case of the abscess type cutaneous nocardiosis].
    Medical mycology journal, 2014, Volume: 55, Issue:1

    Topics: Abscess; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Middle Aged; Nocardia; Nocardia Infections; Skin Diseases, Bacterial; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2014
[Role of ceftaroline in skin and soft tissue infections].
    Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32 Suppl 2

    Topics: Ceftaroline; Cephalosporins; Humans; Skin Diseases, Bacterial; Soft Tissue Infections

2014
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    The Pediatric infectious disease journal, 2014, Volume: 33, Issue:8

    Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Serotyping; Skin Diseases, Bacterial; Soft Tissue Infections

2014
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patients.
    Hospital practice (1995), 2014, Volume: 42, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Drug Utilization; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Skin Diseases, Bacterial

2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections in obese patients.
    Postgraduate medicine, 2014, Volume: 126, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Humans; Length of Stay; Male; Middle Aged; Obesity; Patient Discharge; Retrospective Studies; Sex Factors; Skin Diseases, Bacterial; Socioeconomic Factors; United States; Young Adult

2014
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139 Suppl 3

    Topics: Aztreonam; Ceftaroline; Cephalosporins; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin

2014
[Therapy of skin and soft tissue infections from surgeon's point of view].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139 Suppl 3

    Topics: Algorithms; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Opportunistic Infections; Postoperative Care; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections

2014
Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency.
    Expert review of clinical pharmacology, 2015, Volume: 8, Issue:1

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia; Renal Insufficiency; Retrospective Studies; Skin Diseases, Bacterial; Young Adult

2015
Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function.
    International journal of antimicrobial agents, 2015, Volume: 45, Issue:4

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Europe; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Monte Carlo Method; Pneumonia, Bacterial; Skin Diseases, Bacterial; Treatment Outcome

2015
Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013.
    Diagnostic microbiology and infectious disease, 2015, Volume: 82, Issue:1

    Topics: Academic Medical Centers; Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Microbial Sensitivity Tests; Respiratory Tract Infections; Skin Diseases, Bacterial; United States

2015
Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP).
    Journal of chemotherapy (Florence, Italy), 2016, Volume: 28, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Registries; Retrospective Studies; Skin Diseases, Bacterial

2016
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:3

    Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pakistan; Proteus; Proteus Infections; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections

2015
Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Skin Diseases, Bacterial; United Kingdom; Young Adult

2015
In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Drug Resistance, Bacterial; Epidemiological Monitoring; Europe; Humans; Microbial Sensitivity Tests; Prevalence; Skin Diseases, Bacterial; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2016
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
    Surgical infections, 2016, Volume: 17, Issue:4

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus

2016
In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012-2014.
    Diagnostic microbiology and infectious disease, 2016, Volume: 86, Issue:2

    Topics: Africa; Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Epidemiological Monitoring; Humans; Microbial Sensitivity Tests; Middle East; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2016
Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.
    Journal of clinical pharmacology, 2017, Volume: 57, Issue:3

    Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Community-Acquired Infections; Computer Simulation; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Models, Biological; Pneumonia, Bacterial; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae

2017
Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.
    The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4

    Topics: Anti-Infective Agents, Urinary; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam

2017
[Bacteriology of cutaneous infections of the child].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15 Suppl 2

    Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Macrolides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Methyltransferases; Penicillin G; Penicillin Resistance; Penicillins; Risk Factors; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes

2008
[Managing children skin and soft tissue infections].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15 Suppl 2

    Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cellulitis; Cephalosporins; Child; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Furunculosis; Fusidic Acid; Humans; Impetigo; Injections, Intravenous; Macrolides; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Penicillins; Pristinamycin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Scalded Skin Syndrome; Staphylococcal Skin Infections; Staphylococcus aureus; Stevens-Johnson Syndrome; Streptococcal Infections; Streptococcus pyogenes

2008
Antimicrobial development in the era of emerging resistance.
    Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:8

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration

2009
Ceftaroline for complicated skin and skin-structure infections.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Staphylococcal Infections

2010
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Europe; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Population Surveillance; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; United States

2010
The problem of complicated skin and skin structure infections: the need for new agents.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections

2010
Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Half-Life; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections

2010
Ceftaroline fosamil: drug profile and clinical data.
    Future microbiology, 2011, Volume: 6, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rabbits; Skin Diseases, Bacterial

2011
Pharmacokinetics of Cefovecin in squirrel monkey (Saimiri sciureus), rhesus macaques (Macaca mulatta), and cynomolgus macaques (Macaca fascicularis).
    Journal of the American Association for Laboratory Animal Science : JAALAS, 2010, Volume: 49, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Dog Diseases; Dogs; Half-Life; Injections, Subcutaneous; Macaca fascicularis; Macaca mulatta; Male; Saimiri; Skin Diseases, Bacterial; Species Specificity

2010
Ceftaroline fosamil (Teflaro) - a new IV cephalosporin.
    The Medical letter on drugs and therapeutics, 2011, Jan-24, Volume: 53, Issue:1356

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Skin Diseases, Bacterial; Staphylococcal Infections

2011
Is cefepime safe for clinical use? A Bayesian viewpoint.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Fever of Unknown Origin; Humans; Incidence; Neutropenia; Skin Diseases, Bacterial; Statistics as Topic; United States

2011
Ceftaroline (Teflaro): a new cephalosporin.
    The Nurse practitioner, 2011, Volume: 36, Issue:11

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Pneumonia, Bacterial; Skin Diseases, Bacterial; Staphylococcal Infections

2011
Early endpoints for acute bacterial skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Aztreonam; Biomarkers; Ceftaroline; Cephalosporins; Female; Humans; Male; Skin Diseases, Bacterial; Vancomycin

2012
In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Europe; Genotype; Humans; Microbial Sensitivity Tests; Middle East; Multilocus Sequence Typing; Skin Diseases, Bacterial

2012
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.
    Infection, 2013, Volume: 41, Issue:2

    Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Sepsis; Skin Diseases, Bacterial; Young Adult

2013
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.
    Diagnostic microbiology and infectious disease, 2004, Volume: 49, Issue:4

    Topics: Anti-Infective Agents; Bacteria; Cefdinir; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Positive Cocci; Humans; Klebsiella; Microbial Sensitivity Tests; North America; Skin Diseases, Bacterial; Soft Tissue Infections

2004
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?
    Diagnostic microbiology and infectious disease, 2006, Volume: 55, Issue:4

    Topics: Administration, Oral; Anti-Infective Agents; Cefdinir; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections

2006
[Clinical evaluation of S-1108 in children].
    The Japanese journal of antibiotics, 1993, Volume: 46, Issue:11

    Topics: Adolescent; Bacteria; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections

1993
Neonatal Pseudomonas putida infection presenting as staphylococcal scalded skin syndrome.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:9

    Topics: Ceftazidime; Cephalosporins; Diagnosis, Differential; Fatal Outcome; Humans; Infant, Newborn; Male; Pseudomonas Infections; Pseudomonas putida; Skin Diseases, Bacterial; Staphylococcal Scalded Skin Syndrome

1998
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
    Journal of dermatological science, 1999, Volume: 19, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin

1999
Subcutaneous nodules with pseudomonas septicaemia in an immunocompetent patient.
    Anaesthesia and intensive care, 1999, Volume: 27, Issue:2

    Topics: Adult; Ceftazidime; Cephalosporins; Community-Acquired Infections; Female; Gentamicins; Humans; Immunocompetence; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin Diseases, Bacterial

1999
Isolation of Dermatophilus congolensis from a cat.
    Journal of veterinary medicine. B, Infectious diseases and veterinary public health, 2000, Volume: 47, Issue:2

    Topics: Actinomycetales; Actinomycetales Infections; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cefoperazone; Cephalosporins; Dermatitis; Gentamicins; Oxytetracycline; Penicillins; Rabbits; Skin Diseases, Bacterial; Streptomycin

2000
Drug eruption induced by cefcapene pivoxil hydrochloride.
    Contact dermatitis, 2001, Volume: 44, Issue:3

    Topics: Cephalosporins; Diagnosis, Differential; Drug Eruptions; Female; Humans; Middle Aged; Patch Tests; Skin Diseases, Bacterial

2001
Attempts to stem Anthrax fears stumble.
    Circulation, 2001, Nov-06, Volume: 104, Issue:19

    Topics: Adrenal Cortex Hormones; Anthrax; Bacillus anthracis; Bioterrorism; Centers for Disease Control and Prevention, U.S.; Cephalosporins; Ciprofloxacin; Contraindications; Doxycycline; Drug Therapy, Combination; Humans; Occupational Exposure; Penicillins; Postal Service; Respiratory Tract Infections; Skin Diseases, Bacterial; Spores, Bacterial; Trimethoprim, Sulfamethoxazole Drug Combination; United States

2001
Oral prodrug enters cephalosporin market.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Nov-01, Volume: 58, Issue:21

    Topics: Administration, Oral; Bacterial Infections; Bronchitis; Cephalosporins; Drug Approval; Drug Interactions; Humans; Pharyngitis; Prodrugs; Skin Diseases, Bacterial; United States; United States Food and Drug Administration

2001